| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
69,384,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Twist Bioscience is a synthetic biology company. Co. has developed multiple products derived from synthetic DNA and its versatile DNA synthesis technology. Co.'s offering consists of two primary product lines, synthetic biology tools and next generation sequencing tools, that address different needs of its customers across a variety of applications, such as synthetic genes, Oligonucleotide, SARS-CoV-2 tools and DNA libraries. Co. has introduced an immunoglobulin G protein offering for its customers focused on drug discovery and development. Utilizing its DNA synthesis platform, Co. has launched a product line of synthetic viral controls in response to the rapid spread of COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
10,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$132,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
23,484 |
32,776 |
32,776 |
62,889 |
| Total Sell Value |
$945,546 |
$1,275,201 |
$1,275,201 |
$2,516,090 |
| Total People Sold |
7 |
8 |
8 |
11 |
| Total Sell Transactions |
22 |
33 |
33 |
45 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Daniels Mark |
See Remarks |
• – – |
2021-02-01 |
4 |
OE |
$26.66 |
$31,086 |
D/D |
1,166 |
69,366 |
|
- |
|
| Daniels Mark |
See Remarks |
• – – |
2021-01-28 |
4 |
AS |
$161.02 |
$60,705 |
D/D |
(377) |
68,200 |
|
- |
|
| Daniels Mark |
See Remarks |
• – – |
2021-01-28 |
4 |
OE |
$8.82 |
$3,325 |
D/D |
377 |
68,577 |
|
- |
|
| Daniels Mark |
See Remarks |
• – – |
2021-01-25 |
4 |
AS |
$193.00 |
$174,665 |
D/D |
(905) |
68,200 |
|
- |
|
| Daniels Mark |
See Remarks |
• – – |
2021-01-25 |
4 |
OE |
$23.33 |
$14,465 |
D/D |
620 |
68,820 |
|
- |
|
| Green Paula |
SVP of Human Resources |
• – – |
2021-01-25 |
4 |
AS |
$193.00 |
$47,478 |
D/D |
(246) |
22,250 |
|
- |
|
| Banyai William |
See Remarks |
• • – |
2021-01-25 |
4 |
AS |
$185.45 |
$2,714,617 |
D/D |
(14,099) |
461,937 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-22 |
4 |
D |
$190.64 |
$192,165 |
D/D |
(1,008) |
395,188 |
|
- |
|
| Thorburn James M |
Chief Financial Officer |
• – – |
2021-01-22 |
4 |
D |
$190.64 |
$53,379 |
D/D |
(280) |
49,171 |
|
- |
|
| Daniels Mark |
See Remarks |
• – – |
2021-01-22 |
4 |
D |
$190.64 |
$28,405 |
D/D |
(149) |
68,485 |
|
- |
|
| Weiss Patrick |
Chief Operating Officer |
• – – |
2021-01-22 |
4 |
D |
$190.64 |
$50,138 |
D/D |
(263) |
53,845 |
|
- |
|
| Green Paula |
SVP of Human Resources |
• – – |
2021-01-22 |
4 |
D |
$190.64 |
$30,312 |
D/D |
(159) |
22,496 |
|
- |
|
| Banyai William |
See Remarks |
• • – |
2021-01-22 |
4 |
D |
$190.64 |
$40,034 |
D/D |
(210) |
476,036 |
|
- |
|
| Finn Patrick John |
Chief Commercial Officer |
• – – |
2021-01-22 |
4 |
D |
$190.64 |
$38,319 |
D/D |
(201) |
44,027 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-20 |
4 |
GA |
$0.00 |
$0 |
I/I |
75,000 |
75,000 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-20 |
4 |
GD |
$207.97 |
$15,597,750 |
D/D |
75,000 |
320,188 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-20 |
4 |
AS |
$209.22 |
$1,048,636 |
D/D |
(5,000) |
396,196 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-19 |
4 |
AS |
$199.36 |
$4,008,132 |
D/D |
(20,000) |
401,196 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-14 |
4 |
AS |
$179.52 |
$1,843,356 |
D/D |
(10,000) |
421,196 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-12 |
4 |
AS |
$159.47 |
$333,751 |
D/D |
(2,000) |
431,196 |
|
- |
|
| Finn Patrick John |
Chief Commercial Officer |
• – – |
2021-01-05 |
4 |
AS |
$132.93 |
$359,177 |
D/D |
(2,702) |
44,228 |
|
- |
|
| Finn Patrick John |
Chief Commercial Officer |
• – – |
2021-01-05 |
4 |
OE |
$8.82 |
$62,895 |
D/D |
2,702 |
46,930 |
|
- |
|
| Weiss Patrick |
Chief Operating Officer |
• – – |
2021-01-04 |
4 |
D |
$141.29 |
$34,192 |
D/D |
(242) |
54,108 |
|
- |
|
| Leproust Emily M. |
President & CEO |
• • – |
2021-01-04 |
4 |
D |
$141.29 |
$107,804 |
D/D |
(763) |
433,196 |
|
- |
|
| Thorburn James M |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
D |
$141.29 |
$37,724 |
D/D |
(267) |
49,451 |
|
- |
|
827 Records found
|
|
Page 23 of 34 |
|
|
